Financial Daily from THE HINDU group of publications
Friday, Feb 13, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Announcements
Marketing - New Products & Services


Ajanta Pharma's Tadalisa to take on Viagra

Our Bureau

Mumbai , Feb 12

AJANTA Pharma Ltd has launched Tadalisâ, a drug for erectile dysfunction in men. Tadalisa is a chemical equivalent of tadalafil and the original patent holder for this drug is Eli Lilly, which also hopes to market the drug in the country under the Cialis brandname.

Tadalafil is reported to have two times faster onset of action compared to sildenafil, a note from Ajanta Pharma said. Sildenafil is better known as Viagra, the brand name under which the drug is sold by its original patent-holder Pfizer Inc. Ajanta Pharma also launched a chemical equivalent of sildenafil, under the brandname Kamagraâ.

Tadalisa is priced at Rs 18 for one tablet of 10 mg or Rs 72 for a pack of four tablets. Its 20 mg tablets are sold at Rs 32 for one tablet and Rs 128 for a pack of four, according to company top-brass.

On whether Tadalisa would cannibalise into Kamagraa's market, the official explained that diabetic patients, for instance, who were not able to take Kamagraa would be able to take Tadalisa instead.

More Stories on : Announcements | New Products & Services | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Ajanta Pharma's Tadalisa to take on Viagra


Leasing out spare capacity — Hind Motors in talks for contract production
Kinetic to bring in just 100 more Aquilas
The bold face of the new preface to Accounting Standards
Corporates go slow on ECB plans — Ratings upgrade on cards; domestic tap also attractive
Reuters shifts jobs from US, UK to Bangalore
Sleek version of Cos Act on cards
Plea to develop profession of internal auditors
Samsung recasts Asian region management
Vedior of Netherlands to pick up 76 per cent stake in Ma Foi
CLB approves Compact Power, HBL Nife merger
Dabur Foods to set up Rs 20-cr multi-fruit processing plant
Pokarna begins trial production
DCA talks soon to harmonise share valuations
Ispat Industries under DCA lens
Arvind, Pantaloon announce tie-up
Wockhardt prescribes 1:2 bonus, higher dividend
Toyota research chief sees future in hybrids
Exports cramp Indica domestic supplies
H.W. Bhatnagar to head BHEL



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line